Amyloid-beta, Tau, and Cognition in Cognitively Normal Older Individuals: Examining the Necessity to Adjust for Biomarker Status in Normative Data

Isabelle Bos, Stephanie J. B. Vos, Willemijn J. Jansen, Rik Vandenberghe, Silvy Gabel, Ainara Estanga, Mirian Ecay-Torres, Jori Tomassen, Anouk den Braber, Alberto Lleo, Isabel Sala, Anders Wallin, Petronella Kettunen, Jose L. Molinuevo, Lorena Rami, Gael Chetelat, Vincent de la Sayette, Magda Tsolaki, Yvonne Freund-Levi, Peter JohannsenGerald P. Novak, Inez Ramakers, Frans R. Verhey, Pieter Jelle Visser, Alzheimer's Disease Neuroimaging Initiative

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number193
Number of pages11
JournalFrontiers in Aging Neuroscience
Volume10
DOIs
Publication statusPublished - 25 Jun 2018

Keywords

  • Alzheimer's disease
  • amyloid-beta
  • tau
  • cognition
  • neuropsychological examination
  • normative data
  • PRECLINICAL ALZHEIMERS-DISEASE
  • CEREBROSPINAL-FLUID BIOMARKERS
  • DIAGNOSTIC-CRITERIA
  • INTERNATIONAL WORKSHOP
  • DEMENTIA
  • IMPAIRMENT
  • ADULTS
  • AGE
  • DECLINE
  • PARTICIPANTS

Cite this

Bos, I., Vos, S. J. B., Jansen, W. J., Vandenberghe, R., Gabel, S., Estanga, A., Ecay-Torres, M., Tomassen, J., den Braber, A., Lleo, A., Sala, I., Wallin, A., Kettunen, P., Molinuevo, J. L., Rami, L., Chetelat, G., de la Sayette, V., Tsolaki, M., Freund-Levi, Y., ... Alzheimer's Disease Neuroimaging Initiative (2018). Amyloid-beta, Tau, and Cognition in Cognitively Normal Older Individuals: Examining the Necessity to Adjust for Biomarker Status in Normative Data. Frontiers in Aging Neuroscience, 10, [193]. https://doi.org/10.3389/fnagi.2018.00193